ES2065946T3 - Vector que contiene un promotor del gen de la beta-actina de pollo para la expresion de un gen deseado. - Google Patents
Vector que contiene un promotor del gen de la beta-actina de pollo para la expresion de un gen deseado.Info
- Publication number
- ES2065946T3 ES2065946T3 ES89111481T ES89111481T ES2065946T3 ES 2065946 T3 ES2065946 T3 ES 2065946T3 ES 89111481 T ES89111481 T ES 89111481T ES 89111481 T ES89111481 T ES 89111481T ES 2065946 T3 ES2065946 T3 ES 2065946T3
- Authority
- ES
- Spain
- Prior art keywords
- expression
- desired gene
- gene
- vector containing
- chicken beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000014509 gene expression Effects 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 239000013598 vector Substances 0.000 title abstract 3
- 101000834253 Gallus gallus Actin, cytoplasmic 1 Proteins 0.000 title 1
- 102000007469 Actins Human genes 0.000 abstract 1
- 108010085238 Actins Proteins 0.000 abstract 1
- 210000004102 animal cell Anatomy 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 238000010348 incorporation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 108091008146 restriction endonucleases Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
- C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
- C12N2830/005—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination repressible enhancer/promoter combination, e.g. KRAB
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/60—Vector systems having a special element relevant for transcription from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/90—Vector systems having a special element relevant for transcription from vertebrates avian
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
UN VECTOR DE EXPRESION PARA LA EXPRESION DE UN GEN DESEADO EN UNA CELULA ANIMAL ES DESCRITO, EL VECTOR CONTIENE UN PROMOTOR DEL GEN (BETA)-ACTIN DE GALLINA O UN DERIVADO DEL MISMO Y MAS ABAJO DEL MISMO UN LUGAR PARA LA ENZIMA DE RESTRICCION PARA LA INCORPORACION DE UN GEN DESEADO. ADEMAS SON DESCRITOS LOS CORRESPONDIENTES VECTORES DE EXPRESION RECOMBINADOS, LOS MICROORGANISMOS TRANSFORMADOS Y LOS PROCESOS PARA LA EXPRESION DEL GEN DESEADO EN UNA CELULA HUESPED.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63157569A JPH025884A (ja) | 1988-06-24 | 1988-06-24 | ニワトリのβ−アクチン遺伝子プロモーターを組み込んだ外来遺伝子発現プラスミド |
JP63312444A JP2824433B2 (ja) | 1988-12-09 | 1988-12-09 | 新規なハイブリッドプロモーターおよびこれを組み込んだ外来遺伝子発現用ベクター |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2065946T3 true ES2065946T3 (es) | 1995-03-01 |
Family
ID=26484966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89111481T Expired - Lifetime ES2065946T3 (es) | 1988-06-24 | 1989-06-23 | Vector que contiene un promotor del gen de la beta-actina de pollo para la expresion de un gen deseado. |
Country Status (8)
Country | Link |
---|---|
US (2) | US5811260A (es) |
EP (1) | EP0351585B1 (es) |
KR (1) | KR100196741B1 (es) |
AT (1) | ATE113656T1 (es) |
AU (1) | AU629554B2 (es) |
CA (1) | CA1339413C (es) |
DE (1) | DE68919140T2 (es) |
ES (1) | ES2065946T3 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2108144A1 (en) * | 1991-03-06 | 1992-09-07 | Jack A. Roth | Methods and compositions for the selective inhibition of gene expression |
US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
US6410010B1 (en) | 1992-10-13 | 2002-06-25 | Board Of Regents, The University Of Texas System | Recombinant P53 adenovirus compositions |
DE4126484A1 (de) * | 1991-08-10 | 1993-02-11 | Bayer Ag | Expressionsvektoren und deren verwendung zur darstellung hiv-resistenter menschlicher zellen fuer therapeutische anwendungen |
US5583035A (en) * | 1992-12-07 | 1996-12-10 | Bayer Aktiengesellschaft | HIV antisense expression vectors |
JPH08116976A (ja) * | 1994-10-20 | 1996-05-14 | Chemo Sero Therapeut Res Inst | 免疫用核酸調製物およびこれを用いた免疫方法 |
US6395549B1 (en) | 1998-10-22 | 2002-05-28 | Medical College Of Georgia Research Institute, Inc. | Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors |
US20020034772A1 (en) * | 1999-06-29 | 2002-03-21 | Orlow Seth J. | Methods and compositions that affect melanogenesis |
JP4851041B2 (ja) * | 1999-11-05 | 2012-01-11 | 協和発酵キリン株式会社 | 細胞内のカルシウムイオンの濃度変化をモニターするトランスジェニック非ヒト哺乳動物 |
CN1771324A (zh) * | 2003-02-03 | 2006-05-10 | 日本免疫股份有限公司 | 动物细胞用高表达载体 |
ATE512232T1 (de) * | 2003-12-03 | 2011-06-15 | Chugai Pharmaceutical Co Ltd | Expressionssystem mit einem säuger-beta-actin- promotor |
AU2005206410A1 (en) * | 2004-01-22 | 2005-08-04 | Dnavec Research Inc. | Method of producing minus strand RNA virus vector with the use of hybrid promoter containing cytomegalovirus enhancer and avian beta-actin promoter |
TWI477602B (zh) | 2006-02-09 | 2015-03-21 | Educational Foundation Jichi Medical Univ | Novel viral vector |
US9333249B2 (en) | 2006-02-09 | 2016-05-10 | Educational Foundation Jichi Medical University | Recombinant baculovirus vaccine |
JP5580598B2 (ja) | 2007-11-15 | 2014-08-27 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | γ−セクレターゼの新規基質EphA7を利用したスクリーニング方法 |
US8865426B2 (en) | 2010-12-17 | 2014-10-21 | Eisai R&D Management Co., Ltd. | Screening method using gelatinase-mediated EphA4 cleavage reaction as an indicator |
EP2703814B1 (en) | 2011-04-25 | 2017-11-01 | Eisai R&D Management Co., Ltd. | Method for detecting neurological disease associated with cognitive dysfunction by measuring epha4 extracellular domain |
BR112014008161A2 (pt) | 2011-10-21 | 2017-04-11 | Intervet Int Bv | vírus da doença de marek não patogênico recombinante, método para a preparação do mesmo, molécula do ácido nucleico, célula hospedeira, vacina para aves domésticas, método para a preparação de uma vacina, uso de um vírus da doença de marek não patogênico recombinante, e, método de vacinação de aves domésticas |
RU2758238C2 (ru) * | 2016-05-12 | 2021-10-26 | Янссен Вэксинс Энд Превеншн Б.В. | Эффективный и сбалансированный двунаправленный промотор |
MA56466A (fr) | 2019-07-01 | 2022-05-11 | Eisai R&D Man Co Ltd | Anticorps anti-epha4 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4740461A (en) * | 1983-12-27 | 1988-04-26 | Genetics Institute, Inc. | Vectors and methods for transformation of eucaryotic cells |
EP0174608A1 (en) * | 1984-09-13 | 1986-03-19 | The Board Of Trustees Of The Leland Stanford Junior University | Beta-actin gene and regulatory elements, preparation and use |
US4963481A (en) * | 1985-12-18 | 1990-10-16 | Genetics Institute Inc | Promoter system |
-
1989
- 1989-06-21 CA CA000603465A patent/CA1339413C/en not_active Expired - Lifetime
- 1989-06-21 AU AU36683/89A patent/AU629554B2/en not_active Expired
- 1989-06-23 AT AT89111481T patent/ATE113656T1/de not_active IP Right Cessation
- 1989-06-23 DE DE68919140T patent/DE68919140T2/de not_active Expired - Lifetime
- 1989-06-23 US US07/373,143 patent/US5811260A/en not_active Expired - Lifetime
- 1989-06-23 KR KR1019890008734A patent/KR100196741B1/ko not_active IP Right Cessation
- 1989-06-23 EP EP89111481A patent/EP0351585B1/en not_active Expired - Lifetime
- 1989-06-23 ES ES89111481T patent/ES2065946T3/es not_active Expired - Lifetime
-
1997
- 1997-03-10 US US08/814,468 patent/US5770400A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0351585A2 (en) | 1990-01-24 |
EP0351585A3 (en) | 1990-05-09 |
DE68919140T2 (de) | 1995-03-23 |
KR100196741B1 (ko) | 1999-06-15 |
US5811260A (en) | 1998-09-22 |
KR910001047A (ko) | 1991-01-30 |
ATE113656T1 (de) | 1994-11-15 |
US5770400A (en) | 1998-06-23 |
DE68919140D1 (de) | 1994-12-08 |
AU629554B2 (en) | 1992-10-08 |
CA1339413C (en) | 1997-09-02 |
AU3668389A (en) | 1990-01-04 |
EP0351585B1 (en) | 1994-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2065946T3 (es) | Vector que contiene un promotor del gen de la beta-actina de pollo para la expresion de un gen deseado. | |
GB1534822A (en) | Dental chairs or like patient supporting devices | |
ES2061512T3 (es) | Polipeptidos de nor-estatina y nor-cicloestatina. | |
ES2054676T5 (es) | Regulacion de transcripcion especifica de semillas. | |
GB2136814B (en) | Dna vectors | |
ES2047007T3 (es) | Procedimiento para el aislamiento de proteinas basicas a partir de mezclas de proteinas. | |
ES8104382A1 (es) | Un procedimiento mejorado para isomerizar xilenos | |
DE3782736T2 (de) | Zuchtverfahren fuer leukocyten. | |
ES2078890T3 (es) | Amino esteroides en c20 a c26. | |
ES2059534T3 (es) | Nuevos derivados benzopiranos antihipertensivos. | |
ES2058479T3 (es) | Compuestos peptidicos. | |
MX9300059A (es) | Promotor y metodo para propporcionar expresion constitutiva de los genes heterologos en un amplio rango de tejidos y organos. | |
ES2037709T3 (es) | Derivados heterociclicos de seis miembros de n,n'-diacilhidrazinas n'-sustituidas. | |
AR241800A1 (es) | Procedimiento para preparar compuestos de eglina y procedimiento para obtener preparados farmaceuticos que incluyan a dichos compuestos de eglina como agente activo. | |
Higashihara et al. | The inhibitory effects of okadaic acid on platelet function | |
ES2080000B1 (es) | Colorantes azo reactivos con las fibras. | |
AU4210389A (en) | Plant elongation factor, promoters, coding sequences and uses | |
AR245956A1 (es) | Vector de adn, cepa bacteriana que lo contiene y metodo para modificar geneticamente una celula vegetal | |
AR241083A2 (es) | Procedimiento para preparar acidos 5-cloro-3-(sustituido)-s-triazol[4,3-a!piridin-7-carboxilicos, utiles como agentes antialergicos | |
NO884429L (no) | Kloning og ekspressjon av transformerende vekstfaktor beta | |
FI864071A (fi) | Promoottorijärjestelmä streptomykeettavektoreita varten | |
DE3563752D1 (en) | Compounds having hypolipemizing activity | |
ES2061652T3 (es) | Polipeptidos que contienen homocicloestatina y cicloestatina como agentes antihipertensivos. | |
CA577362A (en) | Power plant for supplying sterilised gas | |
JPS525441A (en) | Booster process of power interruptionless power supply system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 351585 Country of ref document: ES |